Active Research

PI Study Title Sponsor Dates
Crispen, Paul (Co-PI) SCOPE 4: Rel B Mediated Redox Regulation of Radiation Therapy National Cancer Instititute 01/01/2011 -
11/30/2015
Erickson, Deborah MIF: A Pro-inflammatory Cytokine as a Novel Target to Reduce Bladder Inflammation Lexington Biomedical Research Institute 07/01/2012 -
06/30/2015
Kyprianou, Natasha Novel Effectors of TGF-Beta Signaling in Prostate Growth Regulation and Tumor Progression National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) 08/15/2010 -
07/31/2014
Strup, Steven Tracking Renal Tumors After Cryoablation Evaluation (TRACE) Gail Medical Incorporated 08/23/2010 -
08/31/2015
Ziada, Ali A 12-Week Randomized, Open-Label, Active Comparator Period Followed by a 12-Week Safety Extension Period to Evaluate the Safety and Efficacy of Fesoterodine in Subjects Aged 6 to 16 Years and > 25 KG with Symptoms of Detrusor Overactivity Assocated with... Pfizer Inc. 06/21/2012 -
06/30/2014
X
Enter your Surgery username.
Enter the password that accompanies your username.
Loading